BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27742627)

  • 1. Does a modified STarT Back Tool predict outcome with a broader group of musculoskeletal patients than back pain? A secondary analysis of cohort data.
    Hill JC; Afolabi EK; Lewis M; Dunn KM; Roddy E; van der Windt DA; Foster NE
    BMJ Open; 2016 Oct; 6(10):e012445. PubMed ID: 27742627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Keele STarT MSK Tool for Patients With Musculoskeletal Pain in United States-based Outpatient Physical Therapy Settings.
    Beneciuk JM; Michener LA; Sigman E; Harrison T; Buzzanca-Fried KE; Lu X; Shan G; Hill JC
    J Pain; 2024 Jul; 25(7):104475. PubMed ID: 38242334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the STarT Back Tool predict health-related quality of life and work ability after an acute/subacute episode with back or neck pain? A psychometric validation study in primary care.
    Forsbrand MH; Grahn B; Hill JC; Petersson IF; Post Sennehed C; Stigmar K
    BMJ Open; 2018 Dec; 8(12):e021748. PubMed ID: 30580256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive recovery for low-risk injuries screened by the short form - Örebro musculoskeletal pain screening questionnaire following road traffic injury: evidence from an inception cohort study in New South Wales, Australia.
    Nguyen H; Rebbeck T; Kifley A; Jagnoor J; Dinh M; Shetty A; Nicholas M; Cameron ID
    BMC Musculoskelet Disord; 2019 Nov; 20(1):531. PubMed ID: 31722704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refinement and validation of a tool for stratifying patients with musculoskeletal pain.
    Dunn KM; Campbell P; Lewis M; Hill JC; van der Windt DA; Afolabi E; Protheroe J; Wathall S; Jowett S; Oppong R; Mallen CD; Hay EM; Foster NE
    Eur J Pain; 2021 Nov; 25(10):2081-2093. PubMed ID: 34101299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the Keele STarT MSK tool predict the risk of poor outcome in non-specific shoulder complaints in primary care in a Dutch population?
    Vries TMB; Deen WE; Lucas C
    Physiotherapy; 2024 Jun; 123():38-46. PubMed ID: 38266396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratified primary care versus non-stratified care for musculoskeletal pain: findings from the STarT MSK feasibility and pilot cluster randomized controlled trial.
    Hill JC; Garvin S; Chen Y; Cooper V; Wathall S; Saunders B; Lewis M; Protheroe J; Chudyk A; Dunn KM; Hay E; van der Windt D; Mallen C; Foster NE
    BMC Fam Pract; 2020 Feb; 21(1):30. PubMed ID: 32046647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of 'PhysioDirect' telephone assessment and advice services for physiotherapy.
    Salisbury C; Foster NE; Hopper C; Bishop A; Hollinghurst S; Coast J; Kaur S; Pearson J; Franchini A; Hall J; Grove S; Calnan M; Busby J; Montgomery AA
    Health Technol Assess; 2013 Jan; 17(2):1-157, v-vi. PubMed ID: 23356839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and reliability of the Dutch STarT MSK tool in patients with musculoskeletal pain in primary care physiotherapy.
    van den Broek AG; Kloek CJJ; Pisters MF; Veenhof C
    PLoS One; 2021; 16(3):e0248616. PubMed ID: 33735303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Persistent Musculoskeletal Pain at 12 Months: A Secondary Analysis of the Optimal Screening for Prediction of Referral and Outcome (OSPRO) Validation Cohort Study.
    Beneciuk JM; Lentz TA; He Y; Wu SS; George SZ
    Phys Ther; 2018 May; 98(5):290-301. PubMed ID: 29669081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic ability of the German version of the STarT Back tool: analysis of 12-month follow-up data from a randomized controlled trial.
    Karstens S; Krug K; Raspe H; Wunderlich M; Hochheim M; Joos S; Hüppe A
    BMC Musculoskelet Disord; 2019 Feb; 20(1):94. PubMed ID: 30819162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting persisting disability in musculoskeletal pain patients with the STarT MSK screening tool: Results from a prospective cohort study.
    Nativ N; Pincus T; Hill J; Ben Ami N
    Musculoskeletal Care; 2023 Dec; 21(4):1005-1010. PubMed ID: 37150894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of PhysioDirect telephone assessment and advice services for patients with musculoskeletal problems: pragmatic randomised controlled trial.
    Salisbury C; Montgomery AA; Hollinghurst S; Hopper C; Bishop A; Franchini A; Kaur S; Coast J; Hall J; Grove S; Foster NE
    BMJ; 2013 Jan; 346():f43. PubMed ID: 23360891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Validity of the STarT Back Tool for Risk of Persistent Disabling Back Pain in a U.S. Primary Care Setting.
    Suri P; Delaney K; Rundell SD; Cherkin DC
    Arch Phys Med Rehabil; 2018 Aug; 99(8):1533-1539.e2. PubMed ID: 29625095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Monitoring of Patients With Chronic Low Back Pain During Physical Therapy Treatment Using the STarT Back Screening Tool.
    Medeiros FC; Costa LOP; Added MAN; Salomão EC; Costa LDCM
    J Orthop Sports Phys Ther; 2017 May; 47(5):314-323. PubMed ID: 28355979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of elevated fear-avoidance beliefs for patients with low back pain: a secondary analysis involving patients enrolled in physical therapy clinical trials.
    George SZ; Fritz JM; Childs JD
    J Orthop Sports Phys Ther; 2008 Feb; 38(2):50-8. PubMed ID: 18349490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Value of Prognostic Screening for Patients With Low Back Pain in Secondary Care.
    Karran EL; Traeger AC; McAuley JH; Hillier SL; Yau YH; Moseley GL
    J Pain; 2017 Jun; 18(6):673-686. PubMed ID: 28153805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can Primary Care for Back and/or Neck Pain in the Netherlands Benefit From Stratification for Risk Groups According to the STarT Back Tool Classification?
    Bier JD; Sandee-Geurts JJW; Ostelo RWJG; Koes BW; Verhagen AP
    Arch Phys Med Rehabil; 2018 Jan; 99(1):65-71. PubMed ID: 28709881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal Screening for Prediction of Referral and Outcome (OSPRO) for Musculoskeletal Pain Conditions: Results From the Validation Cohort.
    George SZ; Beneciuk JM; Lentz TA; Wu SS; Dai Y; Bialosky JE; Zeppieri G
    J Orthop Sports Phys Ther; 2018 Jun; 48(6):460-475. PubMed ID: 29629615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.